Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Calpain-1 weakens the nuclear envelope and promotes the release of neutrophil extracellular traps (2024) Singh J, Zlatar L, Munoz Becerra M, Lochnit G, Herrmann I, Pfister F, Janko C, et al. Journal article Portable polygraphic device (Somnocheck micro CARDIO®) provides accurate diagnostic information in psychiatric patients at risk for obstructive sleep apnoea: an observational cohort study (2024) Bailer M, Stein EM, Sprügel M, Mestermann S, Spitzer P, Utz J, Zirlik S, et al. Journal article A novel Slide-seq based image processing software to identify gene expression at the single cell level (2024) Götz T, Cong X, Rauber S, Angeli MR, Lang EW, Ramming A, Schmidkonz C Journal article Linking IL-10 signaling with lipid metabolic programs in macrophages: dysregulated ceramide homeostasis drives colitis (2024) Atreya I, Neurath M Journal article Multispectral optoacoustic tomography of benign parotid tumors in vivo: a prospective observational pilot study (2024) Kouka M, Waldner M, Guntinas-Lichius O Journal article Add-on multiple submucosal injections of the RNA oligonucleotide GUT-1 to anti-TNF antibody treatment in patients with moderate-to-severe ulcerative colitis: an open-label, proof-of concept study (2024) Suzuki K, Sameshima Y, Yokoyama J, Terai S, Yoneyama H, Atreya R, Neurath M, et al. Journal article Gastric neuroendocrine neoplasms (2024) Lamberti G, Panzuto F, Pavel ME, O’Toole D, Ambrosini V, Falconi M, Garcia-Carbonero R, et al. Journal article Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials (2024) Peyrin‐Biroulet L, Arkkila P, Armuzzi A, Danese S, Ferrante M, Jordi Guardiola , Jahnsen J, et al. Journal article Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study (2024) Fischer S, Donhauser M, Cohnen SE, Fietkau K, Vetter M, Grübel-Liehr M, Dietrich P, et al. Journal article Tailored Bisacylphosphane Oxides for Precise Induction of Oxidative Stress-Mediated Cell Death in Biological Systems (2024) Almahayni K, Bachir Salvador J, Conti R, Widera A, Spiekermann M, Wehner D, Grützmacher H, Möckl L Journal article